Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

microsatellite instability-high

  • Open Access
    Remarkable and Durable Tumor Response to Pembrolizumab in Locally Advanced dMMR/MSI-H Rectal Cancer
    AYUMU HOSOKAWA, RIN YAMADA, YUKIKO OTSUKI, HOTAKA TAMURA, AKIKO ICHIHARA, TSUYOSHI FUKUSHIMA and YOSHIHIRO KOMOHARA
    Anticancer Research November 2025, 45 (11) 5069-5076; DOI: https://doi.org/10.21873/anticanres.17847
  • You have access
    Pathological Complete Response to Liver Metastasis With Pembrolizumab in a Previously Treated Patient With Microsatellite Instability-high Colorectal Cancer
    AYUMU HOSOKAWA, HOTAKA TAMURA, AKIKO ICHIHARA, NAOYA IMAMURA, KENGO KAI, TSUYOSHI FUKUSHIMA, ATSUSHI NANASHIMA and YOSHIHIRO KOMOHARA
    Anticancer Research September 2024, 44 (9) 4119-4125; DOI: https://doi.org/10.21873/anticanres.17241
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire